Blume Capital Management »

Lexicon Pharmaceuticals shares owned by Blume Capital Management

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Blume Capital Management from 13F filings

Historical chart of Blume Capital Management investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Blume Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Blume Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $12 5 2.40

More positions owned by Blume Capital Management

Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Apple (AAPL)
Vanguard Instl Index 0 3 Mo Tr Bi Etf (VBIL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Applied Materials (AMAT)
Citigroup Com New (C)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Amazon (AMZN)
Dimensional Etf Trust Core Fixe In Etf (DFCF)
Select Sector Spdr Tr St Str Energ Etf (XLE)
Charles Schwab Corporation (SCHW)
Freeport Mcmoran CL B (FCX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)

View all positions for Blume Capital Management

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
Sessa Capital IM
BlackRock
Vanguard Capital Management
Point72 Asset Management
Geode Capital Management
Vanguard Portfolio Management
Citadel Advisors
Northern Trust
Charles Schwab Investment Management
Sixth Street Partners Management Company
Vanguard Fiduciary Trust
Susquehanna International

View all funds holding Lexicon Pharmaceuticals